PIMG
IBB icon

Patriot Investment Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Patriot Investment Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Sell
7,937
-810
-9% -$139K 0.09% 95
2026
Q1 		$1.48M Sell
8,747
-329
-4% -$56.3K 0.09% 91
2025
Q4 		$1.53M Hold
9,076
– – 0.1% 89
2025
Q3 		$1.31M Hold
9,076
– – 0.09% 96
2025
Q2 		$1.15M Sell
9,076
-836
-8% -$103K 0.08% 103
2025
Q1 		$1.27M Sell
9,912
-195
-2% -$26.4K 0.1% 91
2024
Q4 		$1.34M Sell
10,107
-55
-0.5% -$7.73K 0.1% 87
2024
Q3 		$1.48M Sell
10,162
-185
-2% -$26.8K 0.11% 83
2024
Q2 		$1.42M Hold
10,347
– – 0.11% 82
2024
Q1 		$1.42M Sell
10,347
-2,246
-18% -$307K 0.11% 83
2023
Q4 		$1.71M Sell
12,593
-172
-1% -$21K 0.15% 71
2023
Q3 		$1.56M Hold
12,765
– – 0.14% 75
2023
Q2 		$1.62M Sell
12,765
-951
-7% -$124K 0.14% 78
2023
Q1 		$1.77M Hold
13,716
– – 0.16% 74
2022
Q4 		$1.88M Sell
13,716
-9
-0.1% -$1.16K 0.16% 74
2022
Q3 		$1.6M Sell
13,725
-22
-0.2% -$2.73K 0.17% 75
2022
Q2 		$1.62M Buy
13,747
+1,322
+11% +$157K 0.16% 81
2022
Q1 		$1.62M Buy
12,425
+2
+0% +$261 0.14% 83
2021
Q4 		$1.9M Buy
12,423
+167
+1% +$25.9K 0.16% 73
2021
Q3 		$1.98M Buy
12,256
+1,570
+15% +$264K 0.18% 68
2021
Q2 		$1.75M Buy
10,686
+67
+0.6% +$10.3K 0.16% 74
2021
Q1 		$1.6M Sell
10,619
-28
-0.3% -$4.45K 0.16% 77
2020
Q4 		$1.61M Buy
10,647
+49
+0.5% +$7K 0.24% 52
2020
Q3 		$1.44M Buy
10,598
+210
+2% +$28.5K 0.17% 70
2020
Q2 		$1.42M Buy
10,388
+679
+7% +$86.6K 0.18% 72
2020
Q1 		$1.05M Buy
9,709
+1,145
+13% +$132K 0.16% 79
2019
Q4 		$1.03M Buy
8,564
+2
+0% +$223 0.13% 102
2019
Q3 		$848K Buy
8,562
+1
+0% +$105 0.12% 111
2019
Q2 		$934K Buy
8,561
+372
+5% +$39.6K 0.13% 104
2019
Q1 		$915K Buy
+8,189
New +$898K 0.13% 101

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Patriot Investment Management Group's IBB Position: Q2 2026 in Review

Patriot Investment Management Group reduced its iShares Biotechnology ETF (IBB) stake by 9.3% in Q2 2026, selling an estimated $139K and leaving 7,937 shares worth $1.51M. The position accounts for 0.09% of the portfolio, ranked #95.

Patriot Investment Management Group first reported a position in IBB in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.98M in Q3 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Patriot Investment Management Group held 7,937 shares of iShares Biotechnology ETF worth $1.51M as of Q2 2026.
  • Patriot Investment Management Group sold 810 iShares Biotechnology ETF shares in Q2 2026, an estimated $139K.
  • iShares Biotechnology ETF made up 0.09% of Patriot Investment Management Group's portfolio in Q2 2026, its #95 holding.
  • Patriot Investment Management Group first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 30 quarters since.
  • Patriot Investment Management Group's iShares Biotechnology ETF position peaked at $1.98M in Q3 2021.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.